Formulation and Drug Delivery

J&J, BMS Team Up on Cardiovascular Therapies

April 19, 2018

Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.

FDA Grants Roche Breakthrough Therapy Designation on Hemophilia Drug

April 19, 2018

The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.

Sartorius Stedim Biotech and Penn State University Announce Biotechnology Partnership

April 16, 2018

Sartorius Stedim Biotech will supply equipment for Penn State’s new Fermentation Facility in the university’s Center of Excellence in Industrial Biotechnology.

Detecting Potential Formulation Roadblocks in Early Drug Development

April 13, 2018

Pharmaceutical Technology will host a panel discussion focused on early drug development on April 24, 2018 at CPhI North America.

Halo Pharma Simplifies Topical Drug Product Development and Manufacturing

April 12, 2018

The contract development and manufacturing organization will discuss its capabilities in topical drug products at CPhI North America, taking place April 24–26, 2018 in Philadelphia, PA.

Sanofi to Invest Roughly $430 Million in Canadian Vaccine Facility

April 12, 2018

The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.

Amgen to Build Next-Generation Biomanufacturing Plant

April 11, 2018

The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.

Lonza Opens Dedicated Cell and Gene Therapy Manufacturing Facility

April 10, 2018

The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.

Roche Acquires Regenerative Medicines Program

April 09, 2018

Roche has acquired a program to develop regenerative therapies for multiple sclerosis.

Lilly, Sigilon Partner on Encapsulated Cell Therapies for Diabetes

April 09, 2018

Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.